Chicago, IL – According to filings with the U.S. Securities and Exchange Commission, Novascan is raising $3,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Craig Davis played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Novascan
NovaScans leadership believes that improving the detection and stratification of cancer be it in initial detection of cancer, during a procedure, or in post-procedural pathology can improve patient outcomes, increase physician economics, and reduce the cost of care. We are committed to commercializing our platform technology for cancer detection and stratification, which we believe offers significant advantages over alternatives in soft tissue cancer detection. NovaScans first product, MarginScan Skin, offers dermatologists the opportunity for fast, predictable healthy tissue sparing skin cancer procedures.

To learn more about Novascan, visit http://www.novascaninc.com/

Contact:
Craig Davis, Chief Executive Officer
312-952-7701
https://www.linkedin.com/in/craig-davis-4023a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved